Transitions in Brief –

Battery Ventures announced last month that Stephen Terry, a former Credit Suisse First Boston executive, joined the firm as a venture partner. Terry will serve as a liaison between the private capital market industry and Battery’s portfolio companies that are seeking additional rounds of funding.

Terry is specifically charged with counseling communications equipment, services and software portfolio companies that are raising additional funds. He will be based in Battery’s San Mateo, Calif., office while serving the full portfolio of Battery investments.

Previously, Terry served as an investment banking director at CSFB’s Technology Group, where was responsible for managing the communications software practice.

Internal medicine practitioner Steven St. Peter, M.D. has joined Apax Partners Inc.’s health-care practice in New York as a general partner.

Most recently, he was a senior associate with The Carlyle Group focusing on health-care buyouts and venture investing. At Apax he will focus on early- and mid-stage medical technology companies, including those in the medical device, drug delivery and diagnostics sectors.

Since the close of its sixth fund last year at $1.1 billion, Apax has invested $90 million in the health-care sector.

In other news, a former managing director for technology investments at Intel Capital has joined Apax as a partner in the IT/telecom group. Alexander Wong will specialize in semiconductor, optical and emerging technology investments out of the firm’s Palo Alto, Calif. offices.

At Intel, Wong led investments in the MEMs, semiconductor, nanotech and display technology arenas, and also served as chief of staff to the president. He will continue in a similar capacity at Apax.

Terence Garnett has joined Venrock Associates as a general partner in the firm’s Menlo Park, Calif., office. He will focus on information technology investments with a specialty in software companies. Garnett previously served as a venture partner with the firm.

Brian Hanson has been named a venture partner at Advanced Technology Ventures (ATV), a venture capital firm based in Waltham, Mass. and Palo Alto, Calif.

Hanson will primarily focus on ATV’s strategic expansion in Canada, and support the firm’s investment activity in New York and New Jersey.

Previously, Hanson was managing director and co-head of M&A at UBS Warburg, where he specialized in the communications industry. He has also held executive-level positions at Morgan Stanley and Gleacher & Co.

Founded in 1979, ATV has more than $1.5 billion in capital under management. The firm in the process of closing its seventh fund, which it hopes to wrap up by year’s end.

Menashe Ezra has joined BRM Capital, a seed- and expansion-stage venture capital firm, as a managing director. He will work to further broaden the firm’s investments in the communications and wireless infrastructure spaces.

Ezra most recently served as vice president of communication networks at Lucent Technologies. Prior to that, he founded and served as chief executive of WaveAccess, which was acquired by Lucent in 1998.

Institutional Venture Partners (IVP) expanded its staff in late October to include Steve Harrick as managing director and Dennis Phelps as principal.

Harrick will work from IVP’s newly opened San Francisco office, where he will focus on expansion-stage venture capital investments within the software and communications sectors, while Phelps will also focus on those sectors from the firm’s Menlo Park, Calif. office.

Harrick previously worked with Highland Capital Partners and Internet Capital Group. At Highland, he focused on enterprise software and Internet technologies. He also worked in new business development at Netscape Communications and in M&A at Morgan Stanley.

Prior to joining IVP, Phelps worked in corporate finance for Hambrecht & Quist, as an associate at Battery Ventures and as director of acquisitions for Internet Capital Group.

Boston Millennia Partners recently announced that Robert Mashal, M.D. has joined the firm as a partner. He will be a member of Millennia’s health-care and life sciences practice area and will focus primarily on drug discovery and development and enabling technologies for the drug development process, including genomics, systems biology and chemical genomics.

Mashal joined Boston Millennia from Vertex Pharmaceuticals where he was the program executive for the MDR program and a member of its Joint Research Committee. Prior to joining Vertex in March 1998, Mashal was an associate at McKinsey & Co., where he advised a variety of clients in the health-care and life sciences industries.

Tom Davin, former chief operating officer of Taco Bell Corp. and a founding executive of its parent company, Tricon Global Restaurants, recently joined Brentwood Associates in the newly created position of operating partner.

In his new role, Davin will work closely with Brentwood portfolio company chief executives to craft competitive strategies and operational programs.

Based in Los Angeles, Brentwood has $800 million under management.

Dr. Dennis Henner, a venture partner with San Francisco-based early-stage health care investment firm MPM Capital LP, has expanded his role to become a general partner there. Henner, who joined the firm in April after 20 years at biotech firm Genentech Inc. of S. San Francisco, including five years as senior vice president of research, joins a roster of six other general partners at MPM. He is to specialize in molecular biology and biotechnology-related investments.

Other recent MPM Capital hires include Carl Weissman, who joined the Cambridge, Mass.-based firm’s BioVentures as a venture partner and Dr. Kazumi Shiosaki, who joined as entrepreneur in residence.

Previously, Weissman served as the founding chief operating officer of Centagenetix, an MPM portfolio company, while Kazumi served as senior vice president of drug discovery at Millennium Pharmaceuticals and at Abbott Laboratories.

Lastly, Skip Klein was named venture partner with both MPM BioVentures and MPM BioEquities, which invests primarily in public health-care companies. He will focus on late-stage private and public market venture capital opportunities. Prior to joining MPM, Klein was an investment analyst, portfolio manager and founder of the T. Rowe Price Health Sciences Fund.

David Coats and Sandra K. Moon have been named general partners at Hamilton Technology Ventures.

Coats, now a venture partner with Windamere Venture Partners, will join the firm at the end of the year to focus on life sciences investments. Moon, who previously worked with Apex Venture Partners and Unitech Research, will focus on the firm’s IT portfolio.

The San Diego-based firm invests mostly in Southern California. The firm typically invests between $1 million and $3 million in seed- and early-stage life sciences, IT and telecommunications companies